FDA: COVID-19 Antigen, Antibody Tests By LuSys Labs Could Give Wrong Results, Shouldn’t Be Used
Tests might’ve been sold under names Luscient Diagnostics, Vivera Pharmaceuticals or EagleDx
Executive Summary
The US FDA on 11 January issued a safety alert that the diagnostics made by LuSys Laboratories could give false-positive or false-negative results. The agency has asked health care providers and others to stop using the tests.